Search

Search Results

##search.searchResults.foundPlural##

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

933

PDF: 463

HTML: 10
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

21-11-2022

https://doi.org/10.4081/dr.2022.9265

1412

PDF: 372

HTML: 21
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1640

PDF: 450

HTML: 72
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

19-06-2023

https://doi.org/10.4081/dr.2023.9755

744

PDF: 351

HTML: 13
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

918

PDF: 470

HTML: 17
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

14-07-2022

https://doi.org/10.4081/dr.2022.9516

1443

PDF: 593

HTML: 17
Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

27-11-2024

https://doi.org/10.4081/dr.2024.10090

519

PDF: 250

HTML: 10
Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

21-11-2022

https://doi.org/10.4081/dr.2022.9469

1167

PDF: 465

HTML: 29
A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang

12-04-2024

https://doi.org/10.4081/dr.2024.9899

855

PDF: 490

HTML: 20
HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

Nhi Thi Uyen Pham, Thuong Van Nguyen, Hao Trong Nguyen

16-10-2023

https://doi.org/10.4081/dr.2023.9854

1077

PDF: 437

HTML: 22
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

727

PDF: 372

SUPPLEMENTARY MATERIAL: 75

HTML: 4
S-MAPA: bridging the gap in psoriasis severity assessment

Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van

28-05-2025

https://doi.org/10.4081/dr.2025.10231

350

PDF: 89
Late reaction to ustekinumab infusion

Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

e2

09-09-2013

https://doi.org/10.4081/dr.2013.e2

3832

PDF: 613

HTML: 259
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

23-11-2022

https://doi.org/10.4081/dr.2022.9476

1262

PDF: 420

HTML: 23
Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

01-07-2025

https://doi.org/10.4081/dr.2025.10315

227

PDF: 52
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1232

PDF: 592

HTML: 138
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1207

PDF: 352

HTML: 39
Bacterial colonization of psoriasis plaques. Is it relevant?

Eva Marcus, Diana Demmler, Andreas Rudolph, Matthias Fischer

e14

05-08-2011

https://doi.org/10.4081/dr.2011.e14

1547

PDF: 704

HTML: 621
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1001

PDF: 543

HTML: 18
Successful treatment of severe psoriasis vulgaris in child with methotrexate injection

Agatha Anindhita, S. Sawitri

01-04-2019

https://doi.org/10.4081/dr.2019.8096

1013

PDF: 456
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

06-06-2023

https://doi.org/10.4081/dr.2023.9722

673

PDF: 389

HTML: 14
Characteristics and decreased Vitiligo Area Scoring Index of vitiligo patients with narrowband-UVB phototherapy in Yogyakarta, Indonesia

Nabila Kirtti Pradipta, Viensa Ryoto, Retno Danarti, Arief Budiyanto

22-05-2023

https://doi.org/10.4081/dr.2023.9708

796

PDF: 406

HTML: 8
Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

Mishari T. Alrubaiaan, Abdullah D. Alhobabi, Raghad M. Alharthi, Saad A. Alsulaiman, Abdullah N. Altasan, Ibrahim M. Momen, Mohammad Almohideb

02-01-2025

https://doi.org/10.4081/dr.2025.10083

472

PDF: 218

HTML: 4

1 - 23 of 23 items

Search

Search Results

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

S-MAPA: bridging the gap in psoriasis severity assessment

Late reaction to ustekinumab infusion

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Bacterial colonization of psoriasis plaques. Is it relevant?

Erythrodermic psoriasis improved by tildrakizumab

Successful treatment of severe psoriasis vulgaris in child with methotrexate injection

A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

Characteristics and decreased Vitiligo Area Scoring Index of vitiligo patients with narrowband-UVB phototherapy in Yogyakarta, Indonesia

Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

authors

reviewers

indexing

dermatopathology

Keywords